These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3856479)

  • 1. Coagulopathy induced by continuous infusion of high doses of human lymphoblastoid interferon.
    Mirro J; Kalwinsky D; Whisnant J; Weck P; Chesney C; Murphy S
    Cancer Treat Rep; 1985 Mar; 69(3):315-7. PubMed ID: 3856479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.
    Mirro J; Dow LW; Kalwinsky DK; Dahl GV; Weck P; Whisnant J; Murphy SB
    Cancer Treat Rep; 1986 Mar; 70(3):363-7. PubMed ID: 3456833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of weekly high-dose human lymphoblastoid interferon.
    Connors JM; Silver HK
    Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia.
    Totan M; Dagdemir A; Ak AR; Albayrak D; Kucukoduk S
    Med Pediatr Oncol; 2001 Apr; 36(4):429-33. PubMed ID: 11260565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulopathy in dogs with shock induced by injection of heartworm extract.
    Kitoh K; Watoh K; Kitagawa H; Sasaki Y
    Am J Vet Res; 1994 Nov; 55(11):1542-7. PubMed ID: 7879977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospectively randomized toxicity study of high-dose versus low-dose treatment strategies for lymphoblastoid interferon.
    Silver HK; Connors JM; Salinas FA
    Cancer Treat Rep; 1985; 69(7-8):743-50. PubMed ID: 4016785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood coagulation changes in children with acute myelogenous leukemia: thrombin effect or proteolysis].
    von Kries R; Ebell W; Jürgens H; Göbel U
    Klin Padiatr; 1984; 196(3):174-7. PubMed ID: 6590923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation factor analysis in patients on long-term anticoagulation.
    Perkins HA; Biben RL
    Calif Med; 1970 Mar; 112(3):1-7. PubMed ID: 5451608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation studies in leptospirosis.
    Jaroonvesama N; Viranuvatti V; Charoenlarp K
    Southeast Asian J Trop Med Public Health; 1975 Dec; 6(4):562-6. PubMed ID: 1084021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of alpha-lymphoblastoid interferon given weekly as treatment of advanced breast cancer.
    Sarna GP; Figlin RA
    Cancer Treat Rep; 1985 May; 69(5):547-9. PubMed ID: 4005877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired coagulopathy owing to parenteral cefamandole: renal failure as a predisposing factor.
    Chang JC
    Ann Clin Lab Sci; 1983; 13(5):418-24. PubMed ID: 6638932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
    Sarna G; Figlin R; McCarthy S
    J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
    McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
    Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
    J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation abnormalities in type 1 Gaucher disease in children.
    Deghady A; Marzouk I; El-Shayeb A; Wali Y
    Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
    Vugrin D; Hood L; Taylor W; Laszlo J
    Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood coagulation disorders in childhood].
    von Kries R; Göbel U
    Monatsschr Kinderheilkd; 1993 Feb; 141(2):137-49. PubMed ID: 8459816
    [No Abstract]   [Full Text] [Related]  

  • 18. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR
    Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.